Name: UMIN ID:
Unique ID issued by UMIN | UMIN000049936 |
---|---|
Receipt number | R000056873 |
Scientific Title | Efficacy and Safety of Nivolumab+Ipilimumab or Pembrolizumab for Patients with Untreated Advanced or Recurrent Non-small Cell Lung Cancer; A Multicenter Retrospective Observational Study |
Date of disclosure of the study information | 2022/12/29 |
Last modified on | 2023/03/03 13:21:46 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2022/12/28 13:26:23 | ||
2 | Update | 2023/03/03 13:21:46 | Recruitment status Date of IRB Anticipated trial start date |